Post-traumatic stress disorder (PTSD) research hub
5 indexed studies · 4 currently recruiting
- authorisedTherapeutic confirmatory (Phase III)
Women victims of violences : PTSD treatment by traumatic memory reactivation under the influence of propranolol (VIOFEM)
This study looks at a new way to treat post-traumatic stress disorder (PTSD) in women who have survived violence. Researchers want to see if taking a common tablet called propranolol before talking about traumatic memories can help calm severe emotional reactions and reduce PTSD symptoms more effectively.
France - recruitingNot Applicable
Adding virtual reality to talking therapy for post-traumatic stress disorder: a feasibility study
This UK study explores whether using a virtual reality (VR) headset at home can support standard talking therapy for post-traumatic stress disorder (PTSD). Adults with PTSD will receive regular therapy sessions, with half also trying home-based VR exercises to see if this combined care is safe, practical, and helpful.
United Kingdom · England - recruitingPhase I and Phase II (Integrated)- Other
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
This study, IMPACT-1, is looking into a new medication called Methylone for people with Post-Traumatic Stress Disorder (PTSD). It's an early-stage study to see if it's safe and how well it might work to reduce symptoms.
Ireland - not yet recruitingPHASE2
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
This study looks at how a specific treatment using psilocybin, given with a type of therapy called ACT, might help adults aged 18-65 who developed PTSD after experiencing domestic abuse. It aims to see if this treatment can reduce their PTSD symptoms.
Canada - not yet recruitingPHASE3
Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin
This study looks into how a special type of melatonin medicine for children might help those aged 2-18 with PTSD who have trouble sleeping. It compares it to a dummy pill to see if it improves sleep, PTSD symptoms, and daily life for both the children and their families.
France